Targeted immunotherapy for moderate-to-severe palmoplantar pustulosis: A network meta-analysis of randomized controlled trials.

Competing Interests: Conflicts of interest Dr Tsen-Fang Tsai has conducted clinical trials or received honoraria for serving as a consultant for AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, EliLilly, Galderma, GSK-Stiefel, Janssen-Cilag, Leo-Pharma, Merck, Novartis, Pfizer Inc, and UCB Pharma. Dr Ya-Chu Tsai has delivered speeches held by AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, EliLilly, Janssen-Cilag, Leo-Pharma, Novartis, Pfizer Inc, Viatris.